Ticker Symbol: RVMD
Revolution Medicines Inc
$31.76 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001628171
Company Profile
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit high-value frontier targets in RAS-addicted cancers. The company possesses sophisticated structure-based drug discovery capabilities built upon deep chemical biology and cancer pharmacology know-how and innovative, proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites.
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 700 Saginaw Dr
Website: revolutionmedicines.com
CEO: Mark Goldsmith
Tags:
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Biological Product (except Diagnostic) Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $29.91
Change:
$5.71
(
23.59%)
Days Range: $23.64 - $31.24
Beta: 1.25
52wk. High: $35.60
52wk. Low: $17.89
Ytd. Change 49.16%
50 Day Moving Average: $29.39
200 Day Moving Average: $27.23
Shares Outstanding: 109169897
Valuation
Market Cap: 326.5B
PE Ratio: -9.50
EPS (TTM): -3.15
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A